Alpheus Medical
Developing a New Drug-Ultrasound Therapy for Glioblastoma
- Business Model
- B2B
- Website
- alpheusmedical.com
- Last Round
- Series BMay 2025
- Rounds
- 3
About
Biotechnology company developing investigational drug-ultrasound combination therapy for brain cancer treatment.
Summary
Alpheus Medical is a Biotech company based in United States. Its most recent funding was a Series B round in May 2025. Investors include OrbiMed, Action Potential Venture Capital and HealthQuest Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...